The evidence is reviewed that particular analogs of vitamin E may act as both antiatherogenic and anti-cancer agents, and possible molecular bases for these actions are discussed.
The evidence is reviewed that particular analogs of vitamin E may act as both antiatherogenic and anti-cancer agents, and possible molecular bases for these actions are discussed. (en)